MK-677 vs GHRP-2/6: separating real GH data from gym lore

What did @sroka.dietcoach actually say?

The honest answer here is: very little that's verifiable. The transcript provided is garbled to the point of being incoherent, likely a failed auto-transcription of Polish-language audio. What we can work from is the caption, which claims all three compounds stimulate growth hormone and IGF-1, positions GHRP-2 as the most potent GH stimulator among the three, describes GHRP-2 and GHRP-6 as requiring subcutaneous injections two to three times daily due to their pulsatile effect, and frames this as a practical muscle-building comparison. The caption also implies MK-677 is a meaningful alternative to injectable peptides for the same goal. These are the core claims we can actually evaluate.

To be clear: the transcript itself contains no usable statements. Phrases like "I took ten years to get him to make a bad job" are not fitness content. They appear to be machine-translation artifacts. We're fact-checking the caption and implied claims, not a coherent spoken argument.

Does the science back this up?

Partially, but the framing overstates the evidence in ways that matter. GHRP-2 and GHRP-6 are synthetic hexapeptides that act as ghrelin mimetics, binding the growth hormone secretagogue receptor (GHSR-1a) to stimulate pulsatile GH release. MK-677 (ibutamoren) is a non-peptide GHSR agonist that works through the same receptor but is orally bioavailable and has a much longer half-life of roughly 24 hours.

The claim that GHRP-2 produces the highest GH stimulation among the three has some support. Cordido et al. (1993, Journal of Clinical Endocrinology and Metabolism) found GHRP-2 to be a potent GH releaser in humans. However, direct head-to-head comparisons with MK-677 at equivalent receptor occupancy are sparse. Patchett et al. (1995, PNAS) established MK-677's oral bioavailability and sustained GH elevation, but "most potent" is a context-dependent claim. Peak GH pulse height is not the same as total GH exposure over 24 hours, and the caption conflates the two.

The pulsatile dosing requirement for GHRPs is accurate. Their short half-lives of under two hours make multiple daily injections pharmacologically necessary, not just a preference.

What did they get wrong (or right)?

They got the basic pharmacology right. GHRP-2 and GHRP-6 do require frequent injection due to short half-life. MK-677 does produce sustained GH and IGF-1 elevation via oral dosing. These are documented, reproducible findings.

Where this content goes wrong is in the implicit framing: that these are reasonable self-administered options for muscle building. None of these compounds are approved by any major regulatory body for muscle hypertrophy. GHRP-2 and GHRP-6 remain research chemicals with no approved human indication. MK-677 has been studied in clinical trials for conditions including muscle wasting and growth hormone deficiency, but it is not an approved drug for healthy adults seeking muscle gain.

The "NAJWYŻSZA moc" (highest potency) claim for GHRP-2 also deserves skepticism. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed MK-677 produced sustained IGF-1 increases of 40 to 89 percent over 12 months in older adults. Whether GHRP-2 at two to three daily injections produces comparable IGF-1 area under the curve is not established by the caption's evidence.

No mention of side effects. That's a significant omission for a 110,000-view video. GHRP-6 is well-documented to cause significant appetite increases. MK-677 raises cortisol and prolactin in some users and can cause insulin resistance with chronic use (Chapman et al., 1996, NEJM).

What should you actually know?

These three compounds work through the same receptor but are not interchangeable. The choice between them is not simply about "which is better for mass." It involves half-life, route of administration, side effect profiles, and importantly, your legal and medical situation.

MK-677's oral route and once-daily dosing look attractive, but the same pharmacokinetic profile that makes it convenient also means sustained cortisol and prolactin elevation, not just GH and IGF-1. That tradeoff is real and underreported in fitness content.

GHRP-2 and GHRP-6 as research chemicals have no standardized purity requirements in most markets. What you're injecting, if you source these outside a licensed compounding pharmacy with certificate of analysis documentation, is genuinely unknown. That's not a regulatory technicality. It's a patient safety issue.

Anyone considering GH secretagogues should have baseline IGF-1, fasting glucose, HbA1c, and cortisol measured before starting. These are not supplements. They have real endocrine effects that require monitoring by a clinician familiar with peptide pharmacology.